Login

New Cement Grinding Center Boosts Development in Northern Morocco | Mohamed Chafiq - CEO of Ciments du Maroc. 00:10:00

Share On Facebook Share On Twitter

Mohamed Chafiq is the CEO of Ciments du Maroc.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Dr. Dan Bloomfield Discusses Abelacimab's Advantages | JOHN GLASSPOOL, CEO, ANTHOS THERAPEUTICS
00:10:00
Grassi Investment Management: 30 Years of Excellence in Wealth Management | Pete Grassi, Sr., Senior Partner, Grassi Investment Management, LLC
00:10:00
Insights from Koen Dejonckheere on Gimv's Strategic Growth and Economic Resilience | Koen Dejonckheere, CEO, GIMV Corporate.
00:10:00
Pay Down Debt or Invest? Expert Advice from Cove Financial Planning | Ben Smith - FOUNDER & FINANCIAL PLANNER of Cove Financial Planning, LLC
00:10:00
QC Copper and Gold: Unveiling a Promising Drill Campaign
00:00:00
Incidence and Prevalence of Clinical Hypertrophic Cardiomyopathy - Dr. Shahid Karim, a Cardiologist at Mayo Clinic
00:10:00
Patriot Lithium’s Nicholas Vickery Discusses North American Projects and Development Plans | Nick Vickery ,CEO , Patriot Lithium Ltd.
00:10:00
Oregon needs a leader who will challenge conventional thinking, innovate, and make state government accountable to the taxpayer|Allen Alley,CEO,pixelworks inc
00:10:00
Our President and CEO, Scott Barbour, leads Advanced Drainage Systems, Inc. with a strong focus on innovation and customer success in sustainable stormwater management solutions​ |Scott Barbour, President and CEO of Advanced Drainage Systems,
00:10:00
The target is zero to one as quickly as possible|Anne Dwane, Partner,Village Global
00:10:00
Phunware Inc (NASDAQ) CEO Alan Knitowski discusses the company's intent to acquire Lyte Technology with Proactive.|Mike Snavely is Chief Executive Officer & Director of Phunware
00:10:00
Initiator Pharma A/S, a biotech company based in Århus, Denmark, focuses on developing the drug candidate IPED2015.

© 2017 - Neuhu+